Eli Lilly gets nod to launch weight-loss drug in Hong Kong

Eli Lilly gets nod to launch weight-loss drug in Hong Kong - Bloomberg News
Oct 27 (Reuters) - Eli Lilly (LLY.N), opens new tab expects to start selling its weight-loss drug in Hong Kong as early as the end of this year, Bloomberg News reported, opens new tab on Sunday. The drugmaker has received approval from the Hong Kong ...
Eli Lilly gets nod to sell weight-loss drug in Hong Kong by year-end - report
Eli Lilly (NYSE:LLY) received approval from the Hong Kong government to launch its weight-loss drug—Mounjaro, with sales expected to begin as early as year-end, Bloomberg reported. The company got approval to sell its tirzepatide injections—branded as Mounjaro—in a device called Kwikpen.
Eli Lilly tells Bloomberg approval received to launch Mounjaro in Hong Kong
Eli Lilly (LLY) expects to start selling its weight-loss drug tirzepatide, branded as Mounjaro, in Hong Kong as early as the end of this year
Eli Lilly Set to Launch Weight-Loss Drug Mounjaro in Hong Kong by Year-End
Eli Lilly to Introduce Mounjaro Weight-Loss Drug in Hong Kong by Year-End Global pharmaceutical giant Eli Lilly is gearing up to launch its weight-loss drug, Mounjaro, in Hong Kong by the end of this
Eli Lilly Gets Nod to Launch Blockbuster Weight-Loss Drug in Hong Kong
Eli Lilly & Co. expects to start selling its highly popular weight-loss drug in Hong Kong as early as the end of this year, potentially making it the first of its kind to become available in the China region.
Eli Lilly’s weight-loss drug Mounjaro set for Hong Kong launch - report
Eli Lilly & Co. (NYSE:LLY) plans to start selling its popular weight-loss medication, Mounjaro, in Hong Kong by the end of this year, potentially becoming the first drug of its kind available in the broader China region,
devdiscourse3d
Major Developments in Health Industry: New Drug Approval, E. coli Safety, and Corporate Controversies
This report summarizes recent health news, covering Eli Lilly's Hong Kong approval for its weight-loss drug, a McDonald's E.
The Associated Press on MSN6h
Stock market today: Asia shares decline as investors await earnings, US elections and economic data
In the bond market, yields edged higher following the latest readings on the U.S. economy. Growth for the overall economy ...
Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast
Eli Lilly said it sees fiscal year 2024 sales of $45.4 billion—$46 billion, compared to prior guidance of $45.4 billion—$46.6 ...
McDonald's, Eli Lilly, Apple: 3 stocks in focus
Morning Brief Hosts Seana Smith and Brad Smith check in on some of Yahoo Finance's top trending tickers: McDonald's (MCD) ...
Wall Street Breakfast Podcast: Volkswagen Readies $4.3B Cost-Cutting Plan
Volkswagen board preparing $4.3B cost-savings plan: report. McDonald's confirms beef patties not to blame for E. coli ...
Stock market today: Nasdaq edges back from its record as chip companies and Eli Lilly slump
U.S. stock indexes edged lower after drops for Eli Lilly and chip companies overshadowed a jump for Google’s parent company.
Yahoo Finance2d
Eli Lilly and Company (LLY)
Eli Lilly (LLY) has reportedly received approval to sell its weight-loss drugs in Hong Kong, according to Bloomberg. Meanwhile, sales of Apple's (AAPL) iPhone 16 are being blocked in Indonesia ...